Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec. | Klin Monbl Augenheilkd | 2024 | 39870365 | PubTator, text mining | PubMed |
| To see with new eyes. | Taiwan J Ophthalmol | 2024 | 39803406 | PubTator, text mining | PubMed |
| Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions. | Yale J Biol Med | 2024 | 39703610 | PubTator, text mining | PubMed |
| Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs. | Transl Vis Sci Technol | 2024 | 39688851 | PubTator, text mining | PubMed |
| Infantile Nystagmus Syndrome-Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials. | Life (Basel) | 2024 | 39598155 | PubTator, text mining | PubMed |
| Phenotypic and Genetic Spectrum in 309 Consecutive Pediatric Patients with Inherited Retinal Disease. | Int J Mol Sci | 2024 | 39596324 | PubTator, text mining | PubMed |
| [Polymorphism and modern diagnostic approaches for Leber congenital amaurosis]. | Vestn Oftalmol | 2024 | 39569776 | PubTator, text mining | PubMed |
| Linking Protein Stability to Pathogenicity: Predicting Clinical Significance of Single-Missense Mutations in Ocular Proteins Using Machine Learning. | Int J Mol Sci | 2024 | 39519200 | PubTator, text mining | PubMed |
| Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review. | Mol Ther | 2024 | 39489915 | PubTator, text mining | PubMed |
| Cas9-targeted-based long-read sequencing for genetic screening of RPE65 locus. | Front Genet | 2024 | 39469149 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Improves Understanding of Inherited Retinal Dystrophies in Korean Patients. | Curr Issues Mol Biol | 2024 | 39451534 | PubTator, text mining | PubMed |
| A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases. | Cells | 2024 | 39451224 | PubTator, text mining | PubMed |
| Advances and Challenges in Gene Therapy for Inherited Retinal Dystrophies: A Comprehensive Review. | Cureus | 2024 | 39439625 | PubTator, text mining | PubMed |
| A novel RPE65 variant p.(Ala391Asp) in Leber congenital amaurosis: a case report and literature review in Japan. | Front Med (Lausanne) | 2024 | 39359914 | PubTator, text mining | PubMed |
| Erratum: RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec. | Klin Monbl Augenheilkd | 2024 | 39353611 | PubTator, text mining | PubMed |
| A Novel Method for Separating Full and Empty Adeno-Associated Viral Capsids Using Ultrafiltration. | Membranes (Basel) | 2024 | 39330535 | PubTator, text mining | PubMed |
| Tenascin-C induces transdifferentiation of retinal pigment epithelial cells in proliferative vitreoretinopathy. | Exp Eye Res | 2024 | 39284505 | PubTator, text mining | PubMed |
| Clinical and molecular findings in children with retinitis pigmentosa. | Ophthalmic Genet | 2024 | 39206744 | PubTator, text mining | PubMed |
| Whole-Exome Analysis for Polish Caucasian Patients with Retinal Dystrophies and the Creation of a Reference Genomic Database for the Polish Population. | Genes (Basel) | 2024 | 39202371 | PubTator, text mining | PubMed |
| Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl. | Doc Ophthalmol | 2024 | 39141279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=8